Loading...
Please wait, while we are loading the content...
Similar Documents
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
| Content Provider | Scilit |
|---|---|
| Author | Angelico, Francesco Burattin, Marco Alessandri, Cesare Ben, Maria Del Lirussi, Flavio |
| Copyright Year | 2007 |
| Description | Non-alcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver, which may progress to non-alcoholic steatohepatitis (NASH) and cirrhosis. It is suspected in persons with elevated aminotransferase levels and features of insulin resistance (or metabolic) syndrome. The pathogenesis of NAFLD is not clear and there is no universal treatment. |
| Related Links | http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005166.pub2/pdf |
| DOI | 10.1002/14651858.cd005166.pub2 |
| Issue Number | 1 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2007-01-24 |
| Access Restriction | Open |
| Subject Keyword | Gastroenterology and Hepatology Insulin Resistance |
| Content Type | Text |